M85.18 identifies skeletal fluorosis occurring at a site not captured by any other specific M85.1x subcategory — meaning a location other than the skull, shoulder, upper arm, forearm, hand, thigh, lower leg, or ankle/foot.
Verified May 8, 2026 · 4 sources ↓
- Status
- Billable
- Chapter
- 13
- Related CPT
- 5
- Region
- Other
Documentation tips
What should appear in the chart to support M85.18.
Source · Editorial brief grounded in 4 cited references ↓
- Explicitly name the affected skeletal site (e.g., 'pelvis,' 'ribs,' 'sternum') — do not use 'other site' as a generic placeholder without clinical justification.
- Document the fluoride exposure history: source (e.g., endemic water supply, industrial exposure, long-term supplementation), duration, and estimated cumulative dose when available.
- Record imaging findings that support the diagnosis — increased bone density, osteosclerosis, ligamentous calcification, or periosteal new bone formation on X-ray, CT, or bone scan.
- Confirm the affected site does not map to a named M85.1x subcategory (shoulder through ankle/foot) before assigning M85.18.
- If multiple sites are documented as fluorotic, switch to M85.19; if a single non-enumerated site is affected, M85.18 is correct.
Related CPT procedures
Procedure codes commonly billed with M85.18. Linking the right diagnosis to the right procedure is what establishes medical necessity.
Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis
Common coding pitfalls
The recurring mistakes coders make with M85.18 and adjacent codes.
Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓
- Billing the parent code M85.1 instead of M85.18 — M85.1 is non-billable and will reject on the claim.
- Using M85.18 when the affected site actually has its own subcategory (e.g., coding M85.18 for a lower leg site instead of M85.161/M85.162/M85.169).
- Coding M85.18 alongside an Excludes1 condition — osteogenesis imperfecta (Q78.0), osteopetrosis (Q78.2), osteopoikilosis (Q78.8), or polyostotic fibrous dysplasia (Q78.1) cannot appear on the same claim.
- Defaulting to M85.18 for multi-site fluorosis — if the record documents involvement at two or more distinct skeletal sites, M85.19 (multiple sites) is the correct code.
Clinical context
Source · Editorial summary grounded in 4 cited references ↓
Skeletal fluorosis is a bone and joint condition caused by chronic excessive fluoride accumulation, which leads to increased bone density, osteosclerosis, and abnormal bone remodeling. M85.18 is the catch-all subcategory under M85.1 for fluorosis affecting anatomical sites not individually enumerated in the M85.11–M85.17 range. Common examples include the thorax, ribs, sternum, pelvis, or sacrum — any skeletal site where fluoride-induced pathology is confirmed but no laterality-specific or site-specific code exists.
Use M85.18 only after ruling out a more specific site code. If the affected area corresponds to a named site with its own subcategory (e.g., M85.161 for right lower leg), use that code instead. If multiple distinct skeletal sites are involved, use M85.19 (multiple sites) rather than stacking M85.18. The parent code M85.1 is non-billable and cannot be submitted on a claim; M85.18 is the billable endpoint when the documented site falls outside the named subcategories.
Note the category-level Excludes1 exclusions for M85: osteogenesis imperfecta (Q78.0), osteopetrosis (Q78.2), osteopoikilosis (Q78.8), and polyostotic fibrous dysplasia (Q78.1). These congenital conditions must never be coded simultaneously with M85.18 — if the underlying etiology is one of those disorders, the M85.x code is incorrect.
Sibling codes
Other billable codes under M85.1 (laterality / anatomic variants).
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 4 cited references ↓
01What sites does M85.18 cover?
02Can I use M85.18 if the patient has fluorosis in both the pelvis and the ribs?
03Is M85.18 a billable code?
04What are the Excludes1 conditions for M85.18?
05Does M85.18 require a 7th character?
06What CPT procedures are commonly associated with M85.18?
07How does M85.18 differ from M85.19?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
Mira AI Scribe
The Mira AI Scribe captures the specific skeletal site affected (e.g., pelvis, ribs, sternum), the source and duration of fluoride exposure, and imaging findings consistent with fluorosis — increased bone density, osteosclerosis, or ligamentous calcification. This prevents a fallback to the non-billable parent M85.1, avoids erroneous use of a site-specific subcategory, and documents the clinical basis needed to defend M85.18 on audit.
See how Mira captures M85.18 documentation